Compare AGNC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGNC | LNTH |
|---|---|---|
| Founded | 2008 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 6.6B |
| IPO Year | 2008 | 2014 |
| Metric | AGNC | LNTH |
|---|---|---|
| Price | $9.62 | $99.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $11.03 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 23.2M | 920.2K |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 13.13% | N/A |
| EPS Growth | ★ 58.06 | N/A |
| EPS | 0.37 | ★ 2.91 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $0.33 | N/A |
| Revenue Next Year | $1.16 | $14.19 |
| P/E Ratio | ★ $26.81 | $34.35 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $9.63 | $49.67 |
| 52 Week High | $12.19 | $111.86 |
| Indicator | AGNC | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 41.11 |
| Support Level | N/A | $99.92 |
| Resistance Level | N/A | $101.24 |
| Average True Range (ATR) | 0.00 | 0.43 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 9.48 |
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.